Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?
- PMID: 23002357
- PMCID: PMC3447267
- DOI: 10.3748/wjg.v18.i35.4855
Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?
Abstract
Primary biliary cirrhosis (PBC) is a progressive cholestatic liver disease characterized by the immune-mediated destruction of biliary epithelial cells in small intrahepatic bile ducts. The disease is characterized by circulating antimitochondrial antibodies (AMAs) as well as disease-specific antinuclear antibodies, cholestatic liver function tests, and characteristic histological features, including granulomas. A variety of organisms are involved in granuloma formation, of which mycobacteria are the most commonly associated. This has led to the hypothesis that mycobacteria may be involved in the pathogenesis of PBC, along with other infectious agents. Additionally, AMAs are found in a subgroup of patients with mycobacterial infections, such as leprosy and pulmonary tuberculosis. Antibodies against species-specific mycobacterial proteins have been reported in patients with PBC, but it is not clear whether these antibodies are specific for the disease. In addition, data in support of the involvement of the role of molecular mimicry between mycobacterial and human mitochondrial antigens as triggers of cross-reactive immune responses leading to the loss of immunological tolerance, and the induction of pathological features have been published. Thus, antibodies against mycobacterial heat shock protein appear to cross-recognize AMA-specific autoantigens, but it is not clear whether these autoantibodies are mycobacterium-species-specific, and whether they are pathogenic or incidental. The view that mycobacteria are infectious triggers of PBC is intriguing, but the data provided so far are not conclusive.
Keywords: Antimitochondrial antibodies; Autoantibody; Autoimmunity; Cholestasis; Heat shock; Infection; Liver disease; Liver failure; Mycobacterium; Tuberculosis.
Figures

Similar articles
-
Antibodies to mycobacterial 65-kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrhosis.Eur J Clin Invest. 1997 Aug;27(8):667-72. doi: 10.1046/j.1365-2362.1997.1690724.x. Eur J Clin Invest. 1997. PMID: 9279530
-
Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis.J Hepatol. 1994 Oct;21(4):673-7. doi: 10.1016/s0168-8278(94)80117-7. J Hepatol. 1994. PMID: 7529275
-
Autoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significance.World J Gastroenterol. 2014 Mar 14;20(10):2606-12. doi: 10.3748/wjg.v20.i10.2606. World J Gastroenterol. 2014. PMID: 24627596 Free PMC article. Review.
-
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis.J Autoimmun. 2004 Jun;22(4):353-62. doi: 10.1016/j.jaut.2004.03.002. J Autoimmun. 2004. PMID: 15120760
-
Bacteria and primary biliary cirrhosis.Clin Rev Allergy Immunol. 2009 Feb;36(1):30-9. doi: 10.1007/s12016-008-8087-9. Clin Rev Allergy Immunol. 2009. PMID: 18498061 Review.
Cited by
-
The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?Can J Gastroenterol Hepatol. 2018 Jun 26;2018:8197937. doi: 10.1155/2018/8197937. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30046564 Free PMC article. Review.
-
Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders.Antibiotics (Basel). 2023 Jun 17;12(6):1068. doi: 10.3390/antibiotics12061068. Antibiotics (Basel). 2023. PMID: 37370387 Free PMC article. Review.
-
Complexities in the relationship between infection and autoimmunity.Curr Allergy Asthma Rep. 2014 Jan;14(1):407. doi: 10.1007/s11882-013-0407-3. Curr Allergy Asthma Rep. 2014. PMID: 24352912 Free PMC article. Review.
-
The Gut-Liver Axis in Cholestatic Liver Diseases.Nutrients. 2021 Mar 21;13(3):1018. doi: 10.3390/nu13031018. Nutrients. 2021. PMID: 33801133 Free PMC article. Review.
References
-
- Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261–1273. - PubMed
-
- Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50:291–308. - PubMed
-
- Neuberger J. Primary biliary cirrhosis. Lancet. 1997;350:875–879. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical